COVID Shots Get 2025 Makeover: FDA Asks for Public Input
Published Date: 5/8/2025
Notice
Summary
The FDA is gathering experts to pick the best COVID-19 vaccine formula for 2025-2026 to keep everyone safe in the U.S. They want your thoughts too, so they’re opening a public comment period. This affects vaccine makers, healthcare providers, and anyone getting vaccinated, helping guide future shots and health plans.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
FDA picks 2025–2026 COVID‑19 formula
The FDA’s Vaccines and Related Biological Products Advisory Committee will meet in an open session to discuss and make recommendations on the selection of the 2025–2026 formula for COVID‑19 vaccines for use in the United States. This meeting guides which vaccine strains and formulations may be recommended for vaccination programs in 2025–2026.
FDA opens public docket for comments
The FDA is establishing a public docket and requesting public comments on the document about the 2025–2026 COVID‑19 vaccine formula. Anyone may submit comments to inform the advisory committee and FDA before they make recommendations.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in